Fertility preservation in ovarian cancer patients.
Maria Luís SantosAna Sofia PaisTeresa Almeida SantosPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2021)
Ovarian cancer is more frequent in post-menopausal women, however it can also occur in young premenopausal women. After diagnosis and cancer staging, health care providers should address the possibility of infertility and might offer fertility preservation options. Chemotherapy, frequently used when treating ovarian cancer, has proven to cause extensive ovarian damage. Standard surgery may be aggressive and the recurrence risk may not be relevant enough to opt for these approaches. Fertility sparing surgery has been progressively accepted and many alternative surgical approaches have proven to be successful in both cancer treatment, fertility preservation and low recurrence rates. Though there are several techniques available for fertility preservation in cancer patients, when dealing with ovarian cancer patients, oocyte and embryo cryopreservation are the only suitable. Ovarian tissue cryopreservation has been largely studied, but no data on ovarian cancer patients exist, due to the risk of reimplanting cancer cells.
Keyphrases
- childhood cancer
- polycystic ovary syndrome
- minimally invasive
- healthcare
- end stage renal disease
- coronary artery bypass
- pregnancy outcomes
- chronic kidney disease
- ejection fraction
- young adults
- breast cancer risk
- squamous cell carcinoma
- lymph node
- electronic health record
- oxidative stress
- surgical site infection
- prognostic factors
- machine learning
- free survival
- papillary thyroid
- robot assisted
- skeletal muscle
- metabolic syndrome
- locally advanced
- adipose tissue
- lymph node metastasis